IL126998A - Potassium, sodium or tris oxaprozin salt pharmaceutical formulations - Google Patents

Potassium, sodium or tris oxaprozin salt pharmaceutical formulations

Info

Publication number
IL126998A
IL126998A IL12699897A IL12699897A IL126998A IL 126998 A IL126998 A IL 126998A IL 12699897 A IL12699897 A IL 12699897A IL 12699897 A IL12699897 A IL 12699897A IL 126998 A IL126998 A IL 126998A
Authority
IL
Israel
Prior art keywords
sodium
potassium
pharmaceutical formulations
salt pharmaceutical
tris
Prior art date
Application number
IL12699897A
Other languages
English (en)
Other versions
IL126998A0 (en
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of IL126998A0 publication Critical patent/IL126998A0/xx
Publication of IL126998A publication Critical patent/IL126998A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
IL12699897A 1996-05-20 1997-05-14 Potassium, sodium or tris oxaprozin salt pharmaceutical formulations IL126998A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1903396P 1996-05-20 1996-05-20
PCT/US1997/007637 WO1997044022A1 (en) 1996-05-20 1997-05-14 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations

Publications (2)

Publication Number Publication Date
IL126998A0 IL126998A0 (en) 1999-09-22
IL126998A true IL126998A (en) 2003-12-10

Family

ID=21791076

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12699897A IL126998A (en) 1996-05-20 1997-05-14 Potassium, sodium or tris oxaprozin salt pharmaceutical formulations

Country Status (20)

Country Link
US (1) US6030643A (xx)
EP (1) EP0901372B1 (xx)
JP (1) JP4185974B2 (xx)
KR (1) KR20000015865A (xx)
CN (1) CN1129429C (xx)
AT (1) ATE299699T1 (xx)
AU (1) AU718030B2 (xx)
BR (1) BR9710448A (xx)
CA (1) CA2255064C (xx)
CZ (1) CZ370298A3 (xx)
DE (1) DE69733752T2 (xx)
ES (1) ES2248850T3 (xx)
IL (1) IL126998A (xx)
NO (1) NO985414L (xx)
NZ (1) NZ332861A (xx)
PL (1) PL330145A1 (xx)
RU (1) RU2197244C2 (xx)
TW (1) TW586929B (xx)
WO (1) WO1997044022A1 (xx)
ZA (1) ZA974366B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2386312A1 (en) * 1999-09-29 2001-04-05 R.P. Scherer Technologies, Inc. Hydrolyzed cellulose granulations of salts of drugs
US6497157B1 (en) * 1999-11-29 2002-12-24 Distek, Inc. Intrinsic dissolution apparatus with stationary sample holder
FR2828810B1 (fr) * 2001-08-27 2005-10-07 Lvmh Rech Composition cosmetique a effet tenseur contenant un polymere d'origine naturelle et un agent hydratant polyhydroxyle
KR100574554B1 (ko) * 2004-05-28 2006-04-27 한미약품 주식회사 니아신의 경구투여용 서방성 조성물
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
US20060229347A1 (en) * 2005-03-30 2006-10-12 Astion Development A/S Treatment of eczemas
WO2006130726A2 (en) * 2005-06-01 2006-12-07 Teva Pharmaceutical Industries, Ltd. Use of ladostigil for the treatment of multiple sclerosis
JP5284967B2 (ja) * 2007-02-01 2013-09-11 武田薬品工業株式会社 打錠障害を生じない錠剤製剤
WO2013142569A1 (en) * 2012-03-22 2013-09-26 Transtech Pharma, Inc. Tris(hydroxymethyl)aminomethane salts of a small-molecule glp1r agonist and pharmaceutical compositions and uses thereof
EP3275433A1 (en) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Sustained release composition comprising micronized tolcapone

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
US4190584A (en) * 1976-08-13 1980-02-26 John Wyeth & Brother Limited Process for preparing oxazoles
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
GB2097389B (en) * 1981-04-28 1984-11-28 Wyeth John & Brother Ltd Oxazole derivative
US4385049A (en) * 1981-05-12 1983-05-24 K-V Pharmaceutical Company Stable high internal phase ratio topical emulsions
US4599359A (en) * 1982-12-09 1986-07-08 Stephen A. Cooper Hydroxyzine-containing analgesic combinations
GB8329326D0 (en) * 1983-11-03 1983-12-07 Wyeth John & Brother Ltd Oxazole derivatives
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US5059626A (en) * 1988-07-25 1991-10-22 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
WO1992007561A1 (fr) * 1990-10-30 1992-05-14 Ss Pharmaceutical Co., Ltd. Preparation d'un gel anti-inflammatoire et analgesique
WO1995007079A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
EP0719156A1 (en) * 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
WO1997044022A1 (en) 1997-11-27
CA2255064A1 (en) 1997-11-27
JP2001503734A (ja) 2001-03-21
ES2248850T3 (es) 2006-03-16
CN1129429C (zh) 2003-12-03
US6030643A (en) 2000-02-29
PL330145A1 (en) 1999-04-26
NZ332861A (en) 2000-08-25
JP4185974B2 (ja) 2008-11-26
ATE299699T1 (de) 2005-08-15
NO985414L (no) 1999-01-19
CZ370298A3 (cs) 1999-05-12
KR20000015865A (ko) 2000-03-15
RU2197244C2 (ru) 2003-01-27
ZA974366B (en) 1998-05-20
AU3059797A (en) 1997-12-09
DE69733752T2 (de) 2006-06-01
CN1225580A (zh) 1999-08-11
AU718030B2 (en) 2000-04-06
BR9710448A (pt) 1999-08-17
NO985414D0 (no) 1998-11-20
EP0901372A1 (en) 1999-03-17
CA2255064C (en) 2006-10-10
EP0901372B1 (en) 2005-07-20
IL126998A0 (en) 1999-09-22
TW586929B (en) 2004-05-11
DE69733752D1 (de) 2005-08-25

Similar Documents

Publication Publication Date Title
EA199800772A1 (ru) Производные 6-фенилпиридил-2-амина
MX9705569A (es) Inhibidores de adhesion celular.
SG158733A1 (en) Cell adhesion inhibitors
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
SI0725779T1 (xx)
MX9800348A (es) Inhibidores de adhesion celular.
ZA943744B (en) Therapeutic substituted guanidines
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
BG104780A (en) Inhibitors of phospholipase enzymes
GB2288732B (en) Pharmaceutical compositions
DE69905170D1 (en) Thiazolopyrimidinderivate
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
YU13301A (sh) Muskarinski agonisti i antagonisti
ZA974366B (en) Potassium, sodium and tris oxaprozin salt pharmaceutical formulations.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
EP1032556A4 (en) PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
NZ330944A (en) Peptide derivatives
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
GB9505082D0 (en) Medicament
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees